Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts

Gastric cancer (GC) is commonly treated by chemotherapy using 5-fluorouracil (5-FU) derivatives and platinum combination, but predictive biomarker remains lacking. We develop patient-derived xenografts (PDXs) from 31 GC patients and treat with a combination of 5-FU and oxaliplatin, to determine biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Deukchae, Chae, Jeesoo, Cho, Sung-Yup, Kang, Wonyoung, Lee, Ahra, Min, Seoyeon, Kang, Jinjoo, Kim, Min Jung, Choi, Jaeyong, Lee, Woochan, Shin, Dongjin, Min, Ahrum, Kim, Yu-Jin, Lee, Kyung-Hun, Kim, Tae-Yong, Suh, Yun-Suhk, Kong, Seong-Ho, Lee, Hyuk-Joon, Kim, Woo-Ho, Park, Hansoo, Im, Seock-Ah, Yang, Han-Kwang, Lee, Charles, Kim, Jong-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355375/
https://www.ncbi.nlm.nih.gov/pubmed/34376661
http://dx.doi.org/10.1038/s41467-021-25122-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355375/
https://www.ncbi.nlm.nih.gov/pubmed/34376661
http://dx.doi.org/10.1038/s41467-021-25122-4

Ejemplares similares